Zimmer Holdings' CEO Discusses Q1 2012 Results - Earnings Call Transcript

Zimmer Holdings (ZMH)

Q1 2012 Earnings Call

April 26, 2012 8:00 am ET


David C. Dvorak - Chief Executive Officer, President and Director

James T. Crines - Chief Financial Officer and Executive Vice President of Finance

Robert J. Marshall - Vice President of Investor Relations and Treasurer


Bruce M. Nudell - Crédit Suisse AG, Research Division

Robert A. Hopkins - BofA Merrill Lynch, Research Division

Daniel Sollof - Barclays Capital, Research Division

Michael N. Weinstein - JP Morgan Chase & Co, Research Division

Matthew S. Miksic - Piper Jaffray Companies, Research Division

Joanne K. Wuensch - BMO Capital Markets U.S.

Derrick Sung - Sanford C. Bernstein & Co., LLC., Research Division

William J. Plovanic - Canaccord Genuity, Research Division

Kristen M. Stewart - Deutsche Bank AG, Research Division

Raj Denhoy - Jefferies & Company, Inc., Research Division

David R. Lewis - Morgan Stanley, Research Division

Larry Biegelsen - Wells Fargo Securities, LLC, Research Division



Good morning, and welcome to Zimmer's First Quarter 2012 Earnings Conference Call. I'm here with our CEO, David Dvorak; and our CFO, Jim Crines. Before we start, I would like to remind you that our discussions during this call will include forward-looking statements. Actual results may differ materially from those indicated by forward-looking statements due to a variety of risks and uncertainties. Please refer to our SEC filings for a detailed discussion of these risks and uncertainties.

Also, the discussions during this call will include certain non-GAAP financial measures. Reconciliations of these measures to the most directly comparable GAAP financial measures are included within the earnings release, which is available on our website at investor.zimmer.com. With that, I'll now turn the call over to David Dvorak. David?

If you liked this article you might like

Zimmer Biomet's Prognosis Is Promising

Zimmer Biomet's Prognosis Is Promising

St. Jude Buying Thoratec Could Resusitate Medtech M&As

Analysts' Actions -- AT&T, Fitbit, Netflix and More

Barbarian At The Gate: Zimmer Holdings (ZMH)

Deal Delay Minor Obstacle for Zimmer

Deal Delay Minor Obstacle for Zimmer